Page last updated: 2024-08-17

kanamycin a and HIV Coinfection

kanamycin a has been researched along with HIV Coinfection in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's9 (90.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Budhathoki, C; Dooley, KE; Dowdy, DW; Farley, JE; Francis, HW; Han, HR; Hong, H1
Leufkens, HGM; Mantel-Teeuwisse, AK; Mavhunga, F; Mekonen, TT; Mengistu, A; Rennie, T; Ruswa, N; Sagwa, EL1
Abdelghani, N; Dawood, H; Naidoo, K; Naidu, N; Padayatchi, N; Perumal, R; Singh, N; Yende-Zuma, N1
Chirehwa, MT; Court, RG; de Vries, N; Gumbo, T; Harding, J; Maartens, G; McIlleron, H; Stewart, A; Wiesner, L1
Admasu, A; Berha, AB; Negash, Z; Sheth, AN; Shibeshi, W; Yimer, G1
Duarte, R; Gaio, R; Oliveira, O; Villar, M1
Boukary, I; Daouda, M; Hanki, Y; Harouna, SH; Morou, S; Piubello, A; Souleymane, MB; Van Deun, A1
Leufkens, HG; Mantel-Teeuwisse, AK; Mavhunga, F; Rennie, T; Ruswa, N; Sagwa, EL1
Adebola, SO; Adedeji, TO; Adefuye, BO; Oladeji, SM; Sogebi, OA1
Allen, J; Bassett, IV; Chetty, S; Freedberg, KA; Giddy, J; Hom, JK; Losina, E; Mazibuko, M; Walensky, RP; Wang, B1

Trials

1 trial(s) available for kanamycin a and HIV Coinfection

ArticleYear
Effect of lidocaine on kanamycin injection-site pain in patients with multidrug-resistant tuberculosis.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2018, 08-01, Volume: 22, Issue:8

    Topics: Adult; Anesthetics, Local; Anti-Bacterial Agents; Cross-Over Studies; Female; HIV Infections; Humans; Injections, Intramuscular; Kanamycin; Lidocaine; Logistic Models; Male; Middle Aged; Pain Measurement; Pain, Procedural; Single-Blind Method; South Africa; Tuberculosis, Multidrug-Resistant

2018

Other Studies

9 other study(ies) available for kanamycin a and HIV Coinfection

ArticleYear
Prevalence of Pre-Existing Hearing Loss Among Patients With Drug-Resistant Tuberculosis in South Africa.
    American journal of audiology, 2020, Jun-08, Volume: 29, Issue:2

    Topics: Adolescent; Adult; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Antitubercular Agents; Audiometry; Auditory Threshold; Cross-Sectional Studies; Female; Hearing Loss; HIV Infections; Humans; Hypoalbuminemia; Kanamycin; Male; Middle Aged; Ototoxicity; Prevalence; Renal Insufficiency; South Africa; Thinness; Tuberculosis, Multidrug-Resistant; Young Adult

2020
Renal function of MDR-TB patients treated with kanamycin regimens or concomitantly with antiretroviral agents.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2017, 12-01, Volume: 21, Issue:12

    Topics: Adult; Anti-HIV Agents; Antitubercular Agents; Female; Follow-Up Studies; Glomerular Filtration Rate; HIV Infections; Humans; Kanamycin; Kaplan-Meier Estimate; Kidney Function Tests; Male; Middle Aged; Namibia; Proportional Hazards Models; Renal Insufficiency; Retrospective Studies; Tenofovir; Tuberculosis, Multidrug-Resistant; Young Adult

2017
Risk of Nephrotoxicity in Patients With Drug-Resistant Tuberculosis Treated With Kanamycin/Capreomycin With or Without Concomitant Use of Tenofovir-Containing Antiretroviral Therapy.
    Journal of acquired immune deficiency syndromes (1999), 2018, 08-15, Volume: 78, Issue:5

    Topics: Adult; Anti-HIV Agents; Antitubercular Agents; Capreomycin; Creatinine; Drug Therapy, Combination; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kanamycin; Kidney; Male; Retrospective Studies; Tenofovir; Tuberculosis, Multidrug-Resistant

2018
Nephrotoxicity and ototoxic symptoms of injectable second-line anti-tubercular drugs among patients treated for MDR-TB in Ethiopia: a retrospective cohort study.
    BMC pharmacology & toxicology, 2019, 05-23, Volume: 20, Issue:1

    Topics: Adolescent; Adult; Aged; Amikacin; Antitubercular Agents; Capreomycin; Child; Child, Preschool; Creatinine; Ethiopia; Female; HIV Infections; Humans; Kanamycin; Kidney Diseases; Male; Middle Aged; Ototoxicity; Retrospective Studies; Tuberculosis, Multidrug-Resistant; Young Adult

2019
Predictors of treatment outcome in multidrug-resistant tuberculosis in Portugal.
    The European respiratory journal, 2013, Volume: 42, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Databases, Factual; Drug Resistance, Bacterial; Drug Resistance, Multiple; Female; Global Health; HIV Infections; Humans; Kanamycin; Male; Middle Aged; Portugal; Regression Analysis; Retrospective Studies; Risk Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult

2013
High cure rate with standardised short-course multidrug-resistant tuberculosis treatment in Niger: no relapses.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2014, Volume: 18, Issue:10

    Topics: Adolescent; Adult; Aged; Body Mass Index; Body Weight; Clofazimine; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Fluoroquinolones; Follow-Up Studies; Gatifloxacin; HIV Infections; Humans; Kanamycin; Male; Middle Aged; Niger; Prospective Studies; Pyrazinamide; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult

2014
Comparing amikacin and kanamycin-induced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohort.
    BMC pharmacology & toxicology, 2015, Dec-10, Volume: 16

    Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Body Weight; Chi-Square Distribution; Child; Child, Preschool; Coinfection; Hearing Loss; Hearing Tests; HIV Infections; Humans; Incidence; Infant; Infant, Newborn; Kanamycin; Logistic Models; Middle Aged; Namibia; Retrospective Studies; Risk Assessment; Risk Factors; Sex Factors; Tuberculosis, Multidrug-Resistant

2015
Clinical predictors of aminoglycoside-induced ototoxicity in drug-resistant Tuberculosis patients on intensive therapy.
    Auris, nasus, larynx, 2017, Volume: 44, Issue:4

    Topics: Adult; Age Factors; Aminoglycosides; Antitubercular Agents; Audiometry, Pure-Tone; Body Mass Index; Coinfection; Comorbidity; Cycloserine; Diabetes Mellitus; Female; Hearing Loss; HIV Infections; Humans; Kanamycin; Levofloxacin; Male; Middle Aged; Nigeria; Prospective Studies; Prothionamide; Pyrazinamide; Risk Factors; Time Factors; Tuberculosis, Multidrug-Resistant; Young Adult

2017
Drug-resistant tuberculosis among HIV-infected patients starting antiretroviral therapy in Durban, South Africa.
    PloS one, 2012, Volume: 7, Issue:8

    Topics: Adult; Anti-Retroviral Agents; CD4 Lymphocyte Count; Cohort Studies; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Kanamycin; Male; Prevalence; Rifampin; South Africa; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant

2012